BBPA PET/CT in Patients With Malignant Tumors

Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Aug 4, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a special imaging technique called BBPA-PET/CT to help doctors better understand and diagnose malignant tumors, which are cancerous growths. The goal is to see how safe this imaging method is and how well it helps in identifying and analyzing these tumors based on their metabolic characteristics. Patients who are suspected of having brain tumors and meet certain health criteria may be eligible to participate in this study. To qualify, individuals need to be at least 18 years old, have a suspected brain tumor based on their doctor’s assessment and imaging results, and have a good overall health status.

If you decide to participate, you can expect to undergo BBPA-PET/CT scans, and if surgery is needed afterward, additional tests will be done to analyze the tumor. This trial is currently recruiting participants of all genders and is focused on adults aged 18 and older. It's important to note that individuals with certain health issues or conditions, such as serious organ dysfunction or allergies to imaging agents, may not be able to participate. Overall, this study aims to improve the way brain tumors are diagnosed, which could lead to better treatment options for patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Have suspected diagnosis of brain tumors, based on clinical performance and imaging results.
• • Meet the indications for PET examination, show a clear indication and no contraindications;
• • Have a performance status of score ≥80 on KPS scale or score 0-1 points on ECOG scale, a relatively good general situation;
• • Does not appear agonal stage, deep coma, over grade 2 major organ dysfunction (heart, lung, liver, kidney and other major organ include), acute or life-threatening status of infection;
• • Be ≥ 18 years of age on day of signing informed consent.
• • Be willing and able to understand the research content and provide written informed consent/assent for the trial.
• Exclusion Criteria:
• • Have a history of imaging agent allergies;
• • Does not meet the PET-CT scan sedation requirements, or there are contraindications for PET-CT examination;
• • Be pregnant or breastfeeding, or expecting to conceive or father children within the projected duration of the trial;
• • Unable to adhere strictly to protocol requirements.